pCMV-PSMC2-mCherry-Neo plasmid
PVT109529
pCMV-PSMC2-mCherry-Neo plasmid Information
Plasmid name: pCMV-PSMC2(human)-mCherry-Neo
Alias: NM_002803.4;MSS1; Nbla10058; RPT1; S7
Gene lenght: 1299
Host: Mammalian cells
Use(s): Gene expression
Fragment type: ORF
Species: Human
Prokaryotic resistance: Kan
Screening marker: Neo/G418
Fluorescent labeling: Red
Promoter: CMV
Replicon: pUC
Growth Strain(s): DH5a
Growth Temperature: 37°C
Vector backbone:
Forward primer: CMV-F
Reverse primer:
Copy number: High
Induction:
pCMV-PSMC2-mCherry-Neo plasmid Description
pCMV-PSMC2-mCherry-Neo is a plasmid suitable for protein expression in mammalian cells.
pCMV-PSMC2-mCherry-Neo plasmid Sequence
1
TAGTTATTAA
TAGTAATCAA
TTACGGGGTC
ATTAGTTCAT
AGCCCATATA
TGGAGTTCCG
61
CGTTACATAA
CTTACGGTAA
ATGGCCCGCC
TGGCTGACCG
CCCAACGACC
CCCGCCCATT
121
GACGTCAATA
ATGACGTATG
TTCCCATAGT
AACGCCAATA
GGGACTTTCC
ATTGACGTCA
181
ATGGGTGGAG
TATTTACGGT
AAACTGCCCA
CTTGGCAGTA
CATCAAGTGT
ATCATATGCC
241
AAGTACGCCC
CCTATTGACG
TCAATGACGG
TAAATGGCCC
GCCTGGCATT
ATGCCCAGTA
301
CATGACCTTA
TGGGACTTTC
CTACTTGGCA
GTACATCTAC
GTATTAGTCA
TCGCTATTAC
361
CATGGTGATG
CGGTTTTGGC
AGTACATCAA
TGGGCGTGGA
TAGCGGTTTG
ACTCACGGGG
421
ATTTCCAAGT
CTCCACCCCA
TTGACGTCAA
TGGGAGTTTG
TTTTGGCACC
AAAATCAACG
481
GGACTTTCCA
AAATGTCGTA
ACAACTCCGC
CCCATTGACG
CAAATGGGCG
GTAGGCGTGT
541
ACGGTGGGAG
GTCTATATAA
GCAGAGCTGG
TTTAGTGAAC
CGTCAGATCC
GCTAGCGCTA
601
CCGGACTCAG
ATCTCGAGCT
CAAGCTTCGA
ATTCGCCACC
atgccggatt
acctcggtgc
661
cgatcagcgg
aagaccaaag
aggatgagaa
ggacgacaag
cccatccgag
ctctggatga
721
gggggatatt
gccttgttga
aaacttatgg
tcagagcact
tactctaggc
agatcaagca
781
agttgaagat
gacattcagc
aacttctcaa
gaaaattaat
gagctcactg
gtattaaaga
841
atctgacact
ggcctggccc
caccagcact
ctgggatttg
gctgcagata
agcagacact
901
ccagagtgaa
cagcctttac
aggttgccag
gtgtacaaag
ataatcaatg
ctgattcgga
961
ggacccaaaa
tacattatca
acgtaaagca
gtttgccaag
tttgtggtgg
accttagtga
1021
tcaggtggca
cctactgaca
ttgaagaagg
gatgagagtg
ggcgtggata
gaaataaata
1081
tcaaattcac
attccattgc
ctcctaagat
tgacccaaca
gttaccatga
tgcaggtgga
1141
agagaaacct
gatgtcacat
acagtgatgt
tggtggctgt
aaggaacaga
ttgagaaact
1201
gcgagaagta
gttgaaaccc
cattacttca
tccagagagg
tttgtgaacc
ttggcattga
1261
gcctcccaag
ggcgtgctgc
tctttggtcc
acccggtaca
ggcaagacac
tctgtgcgcg
1321
ggcagttgct
aatcggactg
atgcgtgctt
cattcgagtt
attggatctg
agcttgtaca
1381
gaaatacgtc
ggtgaggggg
ctcgaatggt
tcgtgaactc
tttgaaatgg
ccagaacaaa
1441
aaaagcctgc
cttatcttct
ttgatgaaat
tgatgctatt
ggaggggctc
gttttgatga
1501
tggtgctgga
ggtgacaatg
aagtgcagag
aacaatgttg
gaactgatca
atcagcttga
1561
tggttttgat
cctagaggca
atattaaagt
gctgatggcc
actaacagac
ctgatacttt
1621
ggatccagca
ctgatgaggc
cagggagatt
ggatagaaaa
attgaattta
gcttgcccga
1681
tctagagggt
cggacccaca
tatttaagat
tcacgctcgt
tcaatgagtg
ttgaaagaga
1741
tatcagattt
gaactgttag
cacgactgtg
tccaaatagc
actggtgctg
agattagaag
1801
cgtctgcaca
gaggctggta
tgtttgccat
cagagcacgg
cgaaaaattg
ctaccgagaa
1861
ggatttcttg
gaagctgtaa
ataaggtcat
taagtcttat
gccaaattca
gtgctactcc
1921
tcgttacatg
acatacaacg
gtggaggcgg
atcaggaggc
ggtggatcAC
CGGTCGCCAC
1981
CATGGTGAGC
AAGGGCGAGG
AGGATAACAT
GGCCATCATC
AAGGAGTTCA
TGCGCTTCAA
2041
GGTGCACATG
GAGGGCTCCG
TGAACGGCCA
CGAGTTCGAG
ATCGAGGGCG
AGGGCGAGGG
2101
CCGCCCCTAC
GAGGGCACCC
AGACCGCCAA
GCTGAAGGTG
ACCAAGGGTG
GCCCCCTGCC
2161
CTTCGCCTGG
GACATCCTGT
CCCCTCAGTT
CATGTACGGC
TCCAAGGCCT
ACGTGAAGCA
2221
CCCCGCCGAC
ATCCCCGACT
ACTTGAAGCT
GTCCTTCCCC
GAGGGCTTCA
AGTGGGAGCG
2281
CGTGATGAAC
TTCGAGGACG
GCGGCGTGGT
GACCGTGACC
CAGGACTCCT
CCCTGCAGGA
2341
CGGCGAGTTC
ATCTACAAGG
TGAAGCTGCG
CGGCACCAAC
TTCCCCTCCG
ACGGCCCCGT
2401
AATGCAGAAG
AAGACCATGG
GCTGGGAGGC
CTCCTCCGAG
CGGATGTACC
CCGAGGACGG
2461
CGCCCTGAAG
GGCGAGATCA
AGCAGAGGCT
GAAGCTGAAG
GACGGCGGCC
ACTACGACGC
2521
TGAGGTCAAG
ACCACCTACA
AGGCCAAGAA
GCCCGTGCAG
CTGCCCGGCG
CCTACAACGT
2581
CAACATCAAG
TTGGACATCA
CCTCCCACAA
CGAGGACTAC
ACCATCGTGG
AACAGTACGA
2641
ACGCGCCGAG
GGCCGCCACT
CCACCGGCGG
CATGGACGAG
CTGTACAAGT
AGCGGCCGCG
2701
ACTCTAGATC
ATAATCAGCC
ATACCACATT
TGTAGAGGTT
TTACTTGCTT
TAAAAAACCT
2761
CCCACACCTC
CCCCTGAACC
TGAAACATAA
AATGAATGCA
ATTGTTGTTG
TTAACTTGTT
2821
TATTGCAGCT
TATAATGGTT
ACAAATAAAG
CAATAGCATC
ACAAATTTCA
CAAATAAAGC
2881
ATTTTTTTCA
CTGCATTCTA
GTTGTGGTTT
GTCCAAACTC
ATCAATGTAT
CTTAAGGCGT
2941
AAATTGTAAG
CGTTAATATT
TTGTTAAAAT
TCGCGTTAAA
TTTTTGTTAA
ATCAGCTCAT
3001
TTTTTAACCA
ATAGGCCGAA
ATCGGCAAAA
TCCCTTATAA
ATCAAAAGAA
TAGACCGAGA
3061
TAGGGTTGAG
TGTTGTTCCA
GTTTGGAACA
AGAGTCCACT
ATTAAAGAAC
GTGGACTCCA
3121
ACGTCAAAGG
GCGAAAAACC
GTCTATCAGG
GCGATGGCCC
ACTACGTGAA
CCATCACCCT
3181
AATCAAGTTT
TTTGGGGTCG
AGGTGCCGTA
AAGCACTAAA
TCGGAACCCT
AAAGGGAGCC
3241
CCCGATTTAG
AGCTTGACGG
GGAAAGCCGG
CGAACGTGGC
GAGAAAGGAA
GGGAAGAAAG
3301
CGAAAGGAGC
GGGCGCTAGG
GCGCTGGCAA
GTGTAGCGGT
CACGCTGCGC
GTAACCACCA
3361
CACCCGCCGC
GCTTAATGCG
CCGCTACAGG
GCGCGTCAGG
TGGCACTTTT
CGGGGAAATG
3421
TGCGCGGAAC
CCCTATTTGT
TTATTTTTCT
AAATACATTC
AAATATGTAT
CCGCTCATGA
3481
GACAATAACC
CTGATAAATG
CTTCAATAAT
ATTGAAAAAG
GAAGAGTCCT
GAGGCGGAAA
3541
GAACCAGCTG
TGGAATGTGT
GTCAGTTAGG
GTGTGGAAAG
TCCCCAGGCT
CCCCAGCAGG
3601
CAGAAGTATG
CAAAGCATGC
ATCTCAATTA
GTCAGCAACC
AGGTGTGGAA
AGTCCCCAGG
3661
CTCCCCAGCA
GGCAGAAGTA
TGCAAAGCAT
GCATCTCAAT
TAGTCAGCAA
CCATAGTCCC
3721
GCCCCTAACT
CCGCCCATCC
CGCCCCTAAC
TCCGCCCAGT
TCCGCCCATT
CTCCGCCCCA
3781
TGGCTGACTA
ATTTTTTTTA
TTTATGCAGA
GGCCGAGGCC
GCCTCGGCCT
CTGAGCTATT
3841
CCAGAAGTAG
TGAGGAGGCT
TTTTTGGAGG
CCTAGGCTTT
TGCAAAGATC
GATCAAGAGA
3901
CAGGATGAGG
ATCGTTTCGC
ATGATTGAAC
AAGATGGATT
GCACGCAGGT
TCTCCGGCCG
3961
CTTGGGTGGA
GAGGCTATTC
GGCTATGACT
GGGCACAACA
GACAATCGGC
TGCTCTGATG
4021
CCGCCGTGTT
CCGGCTGTCA
GCGCAGGGGC
GCCCGGTTCT
TTTTGTCAAG
ACCGACCTGT
4081
CCGGTGCCCT
GAATGAACTG
CAAGACGAGG
CAGCGCGGCT
ATCGTGGCTG
GCCACGACGG
4141
GCGTTCCTTG
CGCAGCTGTG
CTCGACGTTG
TCACTGAAGC
GGGAAGGGAC
TGGCTGCTAT
4201
TGGGCGAAGT
GCCGGGGCAG
GATCTCCTGT
CATCTCACCT
TGCTCCTGCC
GAGAAAGTAT
4261
CCATCATGGC
TGATGCAATG
CGGCGGCTGC
ATACGCTTGA
TCCGGCTACC
TGCCCATTCG
4321
ACCACCAAGC
GAAACATCGC
ATCGAGCGAG
CACGTACTCG
GATGGAAGCC
GGTCTTGTCG
4381
ATCAGGATGA
TCTGGACGAA
GAGCATCAGG
GGCTCGCGCC
AGCCGAACTG
TTCGCCAGGC
4441
TCAAGGCGAG
CATGCCCGAC
GGCGAGGATC
TCGTCGTGAC
CCATGGCGAT
GCCTGCTTGC
4501
CGAATATCAT
GGTGGAAAAT
GGCCGCTTTT
CTGGATTCAT
CGACTGTGGC
CGGCTGGGTG
4561
TGGCGGACCG
CTATCAGGAC
ATAGCGTTGG
CTACCCGTGA
TATTGCTGAA
GAGCTTGGCG
4621
GCGAATGGGC
TGACCGCTTC
CTCGTGCTTT
ACGGTATCGC
CGCTCCCGAT
TCGCAGCGCA
4681
TCGCCTTCTA
TCGCCTTCTT
GACGAGTTCT
TCTGAGCGGG
ACTCTGGGGT
TCGAAATGAC
4741
CGACCAAGCG
ACGCCCAACC
TGCCATCACG
AGATTTCGAT
TCCACCGCCG
CCTTCTATGA
4801
AAGGTTGGGC
TTCGGAATCG
TTTTCCGGGA
CGCCGGCTGG
ATGATCCTCC
AGCGCGGGGA
4861
TCTCATGCTG
GAGTTCTTCG
CCCACCCTAG
GGGGAGGCTA
ACTGAAACAC
GGAAGGAGAC
4921
AATACCGGAA
GGAACCCGCG
CTATGACGGC
AATAAAAAGA
CAGAATAAAA
CGCACGGTGT
4981
TGGGTCGTTT
GTTCATAAAC
GCGGGGTTCG
GTCCCAGGGC
TGGCACTCTG
TCGATACCCC
5041
ACCGAGACCC
CATTGGGGCC
AATACGCCCG
CGTTTCTTCC
TTTTCCCCAC
CCCACCCCCC
5101
AAGTTCGGGT
GAAGGCCCAG
GGCTCGCAGC
CAACGTCGGG
GCGGCAGGCC
CTGCCATAGC
5161
CTCAGGTTAC
TCATATATAC
TTTAGATTGA
TTTAAAACTT
CATTTTTAAT
TTAAAAGGAT
5221
CTAGGTGAAG
ATCCTTTTTG
ATAATCTCAT
GACCAAAATC
CCTTAACGTG
AGTTTTCGTT
5281
CCACTGAGCG
TCAGACCCCG
TAGAAAAGAT
CAAAGGATCT
TCTTGAGATC
CTTTTTTTCT
5341
GCGCGTAATC
TGCTGCTTGC
AAACAAAAAA
ACCACCGCTA
CCAGCGGTGG
TTTGTTTGCC
5401
GGATCAAGAG
CTACCAACTC
TTTTTCCGAA
GGTAACTGGC
TTCAGCAGAG
CGCAGATACC
5461
AAATACTGTC
CTTCTAGTGT
AGCCGTAGTT
AGGCCACCAC
TTCAAGAACT
CTGTAGCACC
5521
GCCTACATAC
CTCGCTCTGC
TAATCCTGTT
ACCAGTGGCT
GCTGCCAGTG
GCGATAAGTC
5581
GTGTCTTACC
GGGTTGGACT
CAAGACGATA
GTTACCGGAT
AAGGCGCAGC
GGTCGGGCTG
5641
AACGGGGGGT
TCGTGCACAC
AGCCCAGCTT
GGAGCGAACG
ACCTACACCG
AACTGAGATA
5701
CCTACAGCGT
GAGCTATGAG
AAAGCGCCAC
GCTTCCCGAA
GGGAGAAAGG
CGGACAGGTA
5761
TCCGGTAAGC
GGCAGGGTCG
GAACAGGAGA
GCGCACGAGG
GAGCTTCCAG
GGGGAAACGC
5821
CTGGTATCTT
TATAGTCCTG
TCGGGTTTCG
CCACCTCTGA
CTTGAGCGTC
GATTTTTGTG
5881
ATGCTCGTCA
GGGGGGCGGA
GCCTATGGAA
AAACGCCAGC
AACGCGGCCT
TTTTACGGTT
5941
CCTGGCCTTT
TGCTGGCCTT
TTGCTCACAT
GTTCTTTCCT
GCGTTATCCC
CTGATTCTGT
6001
GGATAACCGT
ATTACCGCCA
TGCAT
//
Caution:
1.This product is FOR RESEARCH USE ONLY!
2.The item is lyophilized form, Please take the powder plasmid by centrifugation at 5000rpm/min for 1min. Add 20μl ddH2O in to the tube of plasmid.Take 2ul plasmid into 100 μ L corresponding competent cell, centrifugal then full coating on plate.
3.Shipping temperature is 2-8℃.
Technical Principle & Methodology
The quality assurance and experimental performance of this biological reagent are rigorously optimized and standardized according to its specific technical pathway:
Recombinant DNA Molecular Cloning and Expression Vector Architecture
(重组DNA分子克隆与表达载体工程构建技术). This ensures maximum reproducibility across clinical research and scientific workflows.